← Return to Index

Autus Valve Pivotal Study

NCT05006404 | Sponsored by Autus Valve Technologies, Inc.

Study Overview

This is a prospective, single-arm, multi-center pivotal study designed to evaluate the safety and effectiveness of the Autus Size-Adjustable Valve. This innovative medical device is intended for pediatric patients requiring surgical pulmonary valve replacement. The key feature of the Autus Valve is its ability to be expanded via a minimally-invasive catheter procedure to accommodate a child's growth, potentially reducing the need for repeated open-heart surgeries.

Progress & Timeline

The study is actively recruiting participants across multiple centers in the United States. This section provides a visual summary of the enrollment progress against the study's goal and highlights the key milestones in its long-term timeline.

Enrollment Status

*Actual enrollment is an analyst estimate. See Sources & Methodology section for details.

Status

Recruiting

Study Start Date

February 5, 2024

Primary Completion

August 2026 (Est.)

Study Completion

February 2036 (Est.)

Participant Eligibility

To be considered for this study, potential participants must meet specific criteria. Below is a summary of the key requirements. Please consult with the study coordinators at the listed locations for a complete evaluation.

Age Range

2 to 21 Years

Sex

All

  • Recommended for surgical pulmonary valve replacement.
  • Has a native or repaired right ventricular outflow tract.
  • Body size suitable for implantation of a study device.
  • One of the following findings: Severe pulmonary stenosis, Moderate or greater pulmonary regurgitation, or a combination of both.
  • Willingness to provide informed written consent.
  • Requires valve replacement in a non-pulmonary position.
  • Has a prosthetic valve at another valve position.
  • Has pulmonary arterial hypertension.
  • Has an active infection requiring systemic antibiotic therapy.
  • Has active endocarditis.
  • Known hypersensitivity to anticoagulants and antiplatelet drugs.
  • Participating in another investigational study of a new drug or device.

Recruiting Locations

This study is being conducted at several leading pediatric hospitals across the country. Click on a location below to view more details, including contact information and principal investigators. If you believe you or your child may be eligible, please reach out to the research coordinator at the nearest facility.

This log provides traceability for key claims presented in the dashboard, following a dual-citation standard to ensure data integrity.

Claim Primary Source Secondary Source / Notes Date Fresh?
Enrollment goal is 50 participants. AutusValve.com Provided NCT05006404.json (lists 65). Primary source prioritized due to being more recent. Jan 2025 Fresh
Actual enrollment is ~10 participants (Estimate). NY-Presbyterian Article Estimate derived from confirmed 4 enrollments at one of six sites. Jun 2024 Fresh
Age range is 18 months to 16 years. Provided NCT05006404.json Boston Children's Page Jan 2025 Fresh